A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)

OBJECTIVES: This study compared the efficacy and safety of subcutaneous (SC) versus intravenous (IV) formulations of tocilizumab in patients with rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs (DMARD). METHODS: Patients (n=1262) were randomly assigned to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Burmester, Gerd R, Rubbert-Roth, Andrea, Cantagrel, Alain, Hall, Stephen, Leszczynski, Piotr, Feldman, Daniel, Rangaraj, Madura J, Roane, Georgia, Ludivico, Charles, Lu, Peng, Rowell, Lucy, Bao, Min, Mysler, Eduardo F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888614/
https://www.ncbi.nlm.nih.gov/pubmed/23904473
http://dx.doi.org/10.1136/annrheumdis-2013-203523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888614/
https://www.ncbi.nlm.nih.gov/pubmed/23904473
http://dx.doi.org/10.1136/annrheumdis-2013-203523

Ejemplares similares